Pendal Group Ltd lessened its position in UnitedHealth Group Inc (NYSE:UNH) by 29.4% during the 2nd quarter, Holdings Channel reports. The firm owned 40,650 shares of the healthcare conglomerate’s stock after selling 16,923 shares during the quarter. Pendal Group Ltd’s holdings in UnitedHealth Group were worth $9,919,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of UNH. Westpac Banking Corp lifted its position in UnitedHealth Group by 17.2% during the 2nd quarter. Westpac Banking Corp now owns 169,306 shares of the healthcare conglomerate’s stock worth $41,312,000 after buying an additional 24,883 shares in the last quarter. Charter Trust Co. raised its holdings in UnitedHealth Group by 16.5% during the 2nd quarter. Charter Trust Co. now owns 9,052 shares of the healthcare conglomerate’s stock worth $2,209,000 after purchasing an additional 1,282 shares during the last quarter. Scott & Selber Inc. raised its holdings in UnitedHealth Group by 4.8% during the 2nd quarter. Scott & Selber Inc. now owns 14,984 shares of the healthcare conglomerate’s stock worth $3,656,000 after purchasing an additional 683 shares during the last quarter. Wedbush Securities Inc. raised its holdings in UnitedHealth Group by 7.9% during the 2nd quarter. Wedbush Securities Inc. now owns 22,977 shares of the healthcare conglomerate’s stock worth $5,607,000 after purchasing an additional 1,684 shares during the last quarter. Finally, Capital Advisors Ltd. LLC raised its holdings in UnitedHealth Group by 235.7% during the 2nd quarter. Capital Advisors Ltd. LLC now owns 235 shares of the healthcare conglomerate’s stock worth $57,000 after purchasing an additional 165 shares during the last quarter. Institutional investors own 85.65% of the company’s stock.

In other news, Director Richard T. Burke sold 10,000 shares of the stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $248.00, for a total value of $2,480,000.00. Following the completion of the sale, the director now owns 187,663 shares of the company’s stock, valued at approximately $46,540,424. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Richard T. Burke sold 5,000 shares of the stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $246.40, for a total value of $1,232,000.00. Following the completion of the sale, the director now directly owns 187,979 shares of the company’s stock, valued at approximately $46,318,025.60. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 37,000 shares of company stock valued at $9,195,620. Insiders own 0.82% of the company’s stock.

NYSE UNH traded up $6.42 during trading hours on Tuesday, reaching $249.62. 211,926 shares of the company’s stock were exchanged, compared to its average volume of 3,510,335. The business’s 50-day moving average price is $251.38. UnitedHealth Group Inc has a one year low of $208.07 and a one year high of $287.94. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.67. The firm has a market capitalization of $235.62 billion, a P/E ratio of 19.36, a price-to-earnings-growth ratio of 1.33 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, topping analysts’ consensus estimates of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The firm had revenue of $60.60 billion during the quarter, compared to the consensus estimate of $60.59 billion. During the same quarter in the prior year, the firm posted $3.14 EPS. The business’s revenue was up 8.0% on a year-over-year basis. Analysts predict that UnitedHealth Group Inc will post 14.82 EPS for the current year.

UNH has been the subject of several recent research reports. Raymond James boosted their price objective on UnitedHealth Group from $265.00 to $300.00 and gave the stock a “buy” rating in a report on Friday, July 19th. Citigroup raised UnitedHealth Group from a “neutral” rating to a “buy” rating and upped their price target for the company from $247.00 to $280.00 in a research note on Friday, May 10th. Zacks Investment Research raised UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price target for the company in a research note on Monday, July 22nd. Bank of America reaffirmed a “buy” rating and issued a $290.00 price target (down from $320.00) on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Finally, ValuEngine cut UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Thursday, April 18th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and eighteen have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $295.06.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: What is the definition of a trade war?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.